Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Mineralys Therapeutics, Inc.(MLYS) | 8,644,579 | 8,903,838 | +259,259 | $106.41M | $141.39M | 95.08% | +$34.98M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 1,167,114 | 1,167,114 | 0 | $9.48M | $7.32M | 4.92% | -$2.16M |